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The co-infection or infection-transfection variants of the T7 RNA polymcrase/vaccinia vector system were used to express S-HT,*Rs in COS-7, 
BSC40 and GH, cells, with co-infection giving ca, J-fold higher lcvcl than infection-transfcction. Binding affinities were similar to those of the 
endogcnous 5-HTIAR, with highest affinities for S-HT and S-OH-DPAT. Functional properties were demonstrated byassays ofagonist-stimulated 
GTPase activity and its inhibition by pertussin toxin. lmmunoblot assays howed expression ofthe unglycosylated and glycosylated receptor protein 
in the membrane and, surprisingly, in the cytosolic fractions. 
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1. INTRODUCTION 2.2. Espr*c~.wiotr of /w S-HTJ? by coinjiwiort urd i,r~~ctbl-trrrrt~~c- 
fiurr 
The vaccinia virus (VV) vector system offers unique 
advantages for transient expression of cDNAs in mam- 
malian eels, including a broad host range and high level 
expression [l]. It is effective for expressing integral 
membrane proteins, including ion channels 121 and 7- 
helix receptors [33. The serotonin 1A receptor (5. 
HTIAR), a member of the 7-helix, G-protein-activating 
receptor family [4,5], is implicated in many pharmacol- 
ogical and behavioral actions including the control of 
cardiovascular functions, pain perception, anxiety and 
depression (for reviews, see [6]). These various functions 
are probably related to the coupling of the 5-HT,*R to 
different effecters: adenylyl cyclase, phospholipase C
and K’ channels [7-91. For these reasons, we have stud- 
ied the use of the vaccinia system for expressing the 
5.HTIAR in a variety of cell types and have character- 
ized the intracellular distribution of the expressed mem- 
brane protein. 
Recombinant plasmid (pTMI-SMTIAR) and a recombinant vac- 
cinL virus (VV:SHTIAR) carrying the S-HT,,+R cDNA were con- 
structed as reported previously [3]. Co-infection was performed by 
infcctingcclls with VV:SHTIAR and the helper VV (vTF7-3). each at 
multiplicity of infection (MOl) of 3-S For infection-transfection, 
6 x IOh cells were first infected with vTF7-3 at MO1 of 3-S. and 
transfccte; with a mixture containing 30 pg. Lipokctin reagent (Be- 
thesda Research Laboratories) and 10 pg pTMI-SHTIAR in 2 ml 
strum-free media for 12 h. 
2,3. Prrpurutiort of ttwttbruw fir binding urtd c?TPusc UWJS 
Cells were lyscd over ice with hypotonic buffer (S mM Tris-HCI, S 
mM EDTA, 100 PM phcnylmcthancsulfonyl fluoride. I pg/rnl apro- 
tinin. pH 7.4) and centrifuged al l.OOO xg for IO min to remove cell 
debris. The supcrnatant was ccntrifugcd at 35,000 xg for 20 min. The 
pellet was washed once in the lysis buffer and recentrifugcdd. Protein 
concentrations were dcurmined according to Lowry et al. [IO] using 
bovine serum albumin as the standard. 
2.4, Acceptor hitditg utrd GTPuse ussup 
2. MATERIALS AND METHODS 
2. I. Cd culture 
Cells were grown in a humidified environment cf 5% CO: at 37°C 
in the following media supplemented with penicillin G (100 U/ml) and 
streptomycin (100 flgml): COS-7 cells in Dnlbeceo’s modified Eagle’s 
medium with 5% fetal bovine serum (FBS) and 2 mM L-glutamine; 
BSC-40 cells in minimum essential medium with 5% FBS and 2 mM 
t_-glutamine; GH, ce!!s in Ham’s F-10 medium with 2.5% FBS and 
15% horse serum. 
Saturation and competitive binding studies were performed with 
[‘Hlserotonin (23.2-29.8 Cilmmol) and analyzed with modification as 
described [I I]. Incubation was carried out in a volume of 0.S ml (SO 
mM Tris-HCI, 1 mM MnCIi, pH 8.2) at room lemperulurc for I h. 
GTPase activity was determined by the method ofCassel and Selinger 
[ 121. The agonist-stimulated low-K,,, GTPase activity was calculated 
by subtracting the high-&, GTPase activity (determined in the pres- 
ence of SO yM unlabeled GTP) from the total GTPasc activity. 
2.5. Itttttttrttobfots 
Corr~spundetrct uchh%: B.Y. I-b, Division of Siology 155-79, &Ii- 
fornia Institute of Technology, Pasadena, CA 91 IZ, USA. Fax: (I) 
(818) 564 8709. 
Cytosolic and membrane fractions were prepared from COS-7cells 
[I 31. Proteins were separated on a 0.1% SDS, 12.5% polyacrylamidc 
gel and transferred onto a BA 85 nitrocellulose (SchIckher a.nd 
8chucll) or Hybond N nylon filler (Amersham Corp.). Proleins were 
detected with a purifid antibody directed against he predicted amino 
acids 242-267 of :ht S-HT,AR [4] by the calorimetric method using 
nitro blue tetrazolium and S-bromo-khloro-3-indolyl-phosphate 
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Fig. I, Stimulation of low-K, GTPase activity by scrotonin and &OH- 
DPAT in COS-7 cells co-infected with VWHTIAR and vTF7-3. The 
high-K,,, (non-specific) GTPase activity and basal low-K,,, (agonist- 
sensitive) GTPase ac:ivity were 7.52 + I .62 nmoVmg protein/min and 
30.44 f 5.61 pmol/mg protein/min. Data arc expressed as percent of 
basal low h:, GTPase activity in each assay, Results are mean + 
S.E.M, from at least three separate coinfcction experiments. 
(Promega) or the chemiluminescence m thod using Lumi-Phos 530 
(Boehringer Mannheim). 
Cell culture media were purchased from Irvine Scientific. Drugs 
were obtained from the following sources: serotonin HCI, dopaminc 
HCI, norcpinephrine HCI, epinephrine and pindolol (Sigma); Z-OH- 
DPAT HBr (8.hydroxy-N,N-di-n-propyl-2-aminotetralin), m anscrin 
HCI and quipatine dimaleate (Research Biochemical Inc.); pertussis 
toxin and cholera toxin (List Biological Laboratories); [‘Hijserotonin 
and [y.“?P]GTP (Du-Pont New England Nuclear). 
3. RESULTS AND DISCUSSION 
When 5-HT,,Rs were expressed with either the co- 
infection or infection-transfection variants of the T7 
RNA polymeraselvaccinia vector system, expression 
peaked at about 24 h postinfection and decreased after 
Tnblc I 







Monkey kidney COS-7 ceils 2.88 * OS6 
Monkey kidney BSC-40 cells 2.57 f 0.61 
Rat pituitary tumor GH, cells 0.75 + 0.12’ 
Infection-transfection in COS-7 0.82 ?I 0,04* 
cclis” 
I.89 f 0.28 
1.92 4 0.24 
I .92 k 0.36 
I .79 10,32 
Data are expressed as mean ? S.E.M., irom at least three independent 
experiments. No specific binding was detected in cells that were unin- 
fected or infected with the wild type VV. 
u COS-7 cells were co-infected with VV:S-HT,,R and vTF7-3. 
“COS-7 cc% were infected with TF7-3 and tra,tsfected with pTMI. 
SHTIAR. 
* PC 0,05, compared to coinfcction in COS-7 cells, Student’s f-test 
4 
Fig. 2. Effects of toxin pretreatment on the stimulation of GTPase 
activity. Pertussis toxin (PTX) and cholera toxin (CTX) were pre- 
activated by incubating with 40 tnM dithiothreitol, and 2 mM ATP 
for 20 min at 37°C. ADP-ribosylation of membranes from co- infected 
COS-7 cells was performed inbuffercontaining IO0 mM Tris-HCI (pH 
7.5). 2O~dml pertussis toxin or 50,ug/ml cholera toxin, IO mM NAD, 
ImM ATP, 6 mM DTT and I mM EDTA for 30 min at 37°C The 
reaction was terminated by the addition of 1 ml ice-cold buffcr(25 mM 
Tris-HCI, 0.1 mM EDTA). Membranes were washed two times in 10 
volumes of the same buffer to remove the toxins and used immediately 
for GTPase assays. Control (no toxin treatment) and toxin cxperi- 
men& were performed simultaneously using the same membranes 
from each coinfection experiment. Data are expressed as the percent 
of the respective basal low-K,,, GTPase activity (in the absence of 
8-OH-DPAT). Results were derived from three separate coinfections 
for PTX pretreatment and two for CTX pretreatment. 
2-3 days (data not shown). Therefore, membranes were 
prepared 24 h postinfection throughout he study. In the 
transfection-infection protocol, cells were infected with 
vTF7-3, which expresses the T7 RNA polymerase, and 
transfected with pTM 1 -5HTlAR, carrying the receptor 
cDNA, driven by an T7 RNA polymerase promoter, 
with the 5’.untranslated region of the encephalomyo- 
carditis virus to enhance cap-independent translation 
[14]. For the co-infection protocol, the 5-HT,,R expres- 
sion cassette of pTMl-5HTl AR was inserted into W 
by homologous recombination to give VV:5-HTlAR, 
and cells were co-infected with vTF7=3 and VV:5- 
HTl AR. Expression levels of the 5-HT,,+Rs in BSC-40 
and CBS-7 cells (approximately 3 pmol/mg protein or 
3 x lo5 receptors/cell) were higher than that in GH2 cells 
(Table I). The latter two cell types were chosen for study 
because they display signal transduction pathways that 
may couple to the expressed 5-HT,*R: namely inhibi- 
tion of adenylate cyclase in COS-7 cells [7] and potas- 
sium channel coupling in GHS cells [9]. Such levels are 
comparable to those of other 7-helix receptors ex- 
pressed in various expression systems [7,15]. When com- 
pared in COS-7 cells, the coinfection protocol was 
about 3-fold as cflicient 2s the infection-trazsfection 
protocol. This is probably because virus infection is 
more efficient han DNA transfection and because of 
intracellular eplication by virus. Competitive binding 
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Fig. 3. Assessment of the 5mHTIA receptor protein in the cytosolic (C) 
and membrane (M) fractions of COS-7 cells after coinfection (CI) or 
infection-transfcction (IT). (aj Control cells were either uninfected 
(UN, lanes 5 and 7) or coinfected with vTF7-3 and vT7EMCAT. a 
virus expressing the CAT gcnc wi:h the same Ranking sequences as 
VV:SHT I AR (CAT, lanes 6 and E), Ten (Cl) or 4Olg protein (IT, UN, 
CAT) was loaded onto each lane, and annlyzcd by 12.5% SDS-PAGE. 
Proteins were immunoblotred and dctcctrd with the chcmilumines- 
cencc method. (b) Cytosolic and membrane fractions from coinicrtcd 
cells (+. lanes 2 and 3) were trcaied with 0.5 U of cndoglycosidasc 
Flglycopeptidasc F (Boehringer Mannheim) for 20 h al 37°C in 20 
mhl potassium phosphate buffer, IO mM EDTA, 0.2% SDS, 1% 
Nonidet P-40, I% P-mercaptocthanol. pH 7.4. Lane I shows the result 
of untreated cylosolic fraction (-) from coinfccted cells. Proteins were 
analyzed as in (a) and dehxted with thccolorimetric method. Numbers 
at the left in (a) and (b) rcprescm the positions of six standards in 
units of kDu. 
assays howed a rank order of potency of S-OH- DPAT 
-5-HT>RU-24,969 > pindolol > mianserin z quipaz- 
ine, and micromolar affinities for other biogenic 
amines, dopamine, epinephrine and norepinephrine 
(Table II). Therefore, the expressed receptor showed a 
5-HT 1 A-type pharmacology [ 161. 
3.2. GTPase acciriry in coinjhxl COW cells 
A functional coupling of the expressed receptor to G 
protein is indicated by its ability to stimulate GTPase 
activity (Fig. 1). The ECS, values for 5-HT and a-OH- 
DPAT are estimated as 2.4 nM and 3.2 nM, respec- 
tively, which are close to the affinities found in the 
binding asays (Table I and II). The increase in GTPase 
activity in response to 8-OH-DPAT was abolished by 
pretreatment with pertussis toxin, but cholera toxin had 
no effect (Fig. 2). Thus, like the endogenous S-HT,,,R 
[ 161, the expressed 5-HTIAR in COS-7 cells acts primar- 
ily through a pertussis toxin-sensitive, cholera toxin- 
insensitive G protein. 
3.3. lnrruceliubr distribution 
The observed values of &,, achieved for the 5- 
HT,,,R in the vaccinkuT7 hybrid expression system, are 
comparable to those achieved in other efficient gene 
transfer systems [7.15]. However, much higher expres- 
sion levels of ca. 10% of total protein were achieved for 
expression of the cytoplasmic protein, chloramphenicol 
acetyltransferase (CAT), using the same VV system [17]. 
This discrepancy has prompted us to examine whether 
additional 5-HTl,,R protein is found in the cytoplasm 
in infected COS-7 cells. Relative levels of expression in 
the membrane rnd cytosolic fractions were compared 
by immunoblots (Fig. 3a). For each of the membrane 
fraction lanes, there was a strong band at 61 kDa, a 
weak band at 57 kDa, and a very weak band at 46 kDa. 
Similar bands were observed in the cytosolic fraction, 
but there was a much greater amount of immunoreac- 
tive protein at the 46.kDa band than the other bands. 
From its translated cDNA sequence, the calculated mo- 
lecular weight of the 5-HTl,R protein is 46 kDa and it 
contains 3 a&nine residues as potential sites for N- 
linked glycosylation. To test whether the higher M, 
components are glycosylated forms of the 46-kDa band, 
the fractions were treated with endoglycosidase F/ 
glycopeptidase F which cleaves glycoproteins at the as- 
paragine to NJ’-diacetylchitobiose bond, leaving a 
completely deglycosylated protein. After treatment, 
only the 46-kDa component remained (Fig. 3b). We 
Table II 
Aflinity of the expressed 5-HT,*R 
Compctitivc ligand pi (IBM) 
.- 
Serotoniii l.l3 2 0.45 
&OWDPAT 0.81 ,c 0.12 
RU-24969 4.74 2 0.44 
Pindolol 17.87 + 2.04 
Mianserin 518 464 
Quipazinc 7 I.000 
Dopamine > I.000 
Norcpinephrinc 710,MJo 
Epiucphrine 7 1.OctO 
Assdys were perfortncd with I nM [‘Hlserotonin and different cornpets 
itivc ligands. K, values were calculated using the Kd value ofco-infected 
COS-7 cells in Table I. The Ki values arc expressed us mean ?r S.E.M. 
from at least three separale coinfection experiments. except for qui- 
paninc. dopamine, and norcpincphrine, thcvaluesof which wcrc deter- 
mined from two experiments. 
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therefore conclude that the 57- and Bl-kDa forms are 
glycosylated. The protein in the cytosolic fraction is 
mostly not glycosylated, whereas most of the protein in 
the membrane fraction as prepared here is glycosylated. 
A quantitative comparison of the amounts of S-HTIAR 
in the membrane and cytosolic fraction was not at- 
tempted; this estimate would require the assumption 
that the glycosylated and nonglycosylated forms are 
equally reactive to the antibody as well as a knowledge 
of the fraction of total cell protein in the membrane 
fr&ction. Assuming the latter quantity is probably in the 
order of 5-10% and immunoreactivities are not grossly 
different between these two forms, the amount of 5- 
HTIAR protein in the cytosol fraction is severalfold 
greater than in the membrane fraction. 
The T7 RNA polymerase/vaccinia vector system has 
the unique advantage of a very broad host range, in- 
cluding primary cells, We have tiemonstrated that the 
system is effective for high level expression of a func- 
tional 7-helix G-protein-coupled receptor in several cell 
types. The unexpected finding is that a high level of 
immunoreactive protein was also found in the cytosolic 
fraction. Wbiie the expression levels achieved are ade- 
quate for pharmacological nd functional studies, they 
are insufficient fos structural studies. To achieve this 
latter goal, it will be necessary to overcome some un- 
known limiting factors on the expression of integral 
membrane proteins that do not apply to cytosolic pro- 
teins. 
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